Nike CEO John Donahoe under fire from Wall Street following Q4 2024 report
John Donahoe attends the first day of the annual Allen & Company Sun Valley Conference in Sun Valley, Idaho. Drew…
S&P 500 Index
Catalyst Calendar: Here's a Look at the Major Events That Could Drive These 7 Stocks Higher
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
The 4 things we're most focused on in the stock market this week
The Nasdaq Composite rose slightly on Friday for its fifth consecutive record close, as new data last week showed a…
9 stocks that can benefit from the Fed's interest rate cuts
The S&P 500 and Nasdaq extended their record rallies this week after consumer inflation data came in better than expected…
US millionaire population grew by 600,000 last year
B2m Productions | Digital vision | fake images The United States far outpaced the rest of the world in creating…
The stock market is again under attack by the Federal Reserve. Plus, the quiet return of Starbucks
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly shares hit new highs after a regulatory victory in China. This is a big problem
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Danaher shows how holding a good company's troubled stock can pay off
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Unjustified drop after GEHC results is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
The promise of Eli Lilly's weight-loss drug for sleep apnea adds reasons to own it
Eli Lilly's weight-loss drug Zepbound showed promise as a treatment for sleep apnea, giving investors more confidence to continue owning…